Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 310

1.

Liver Imaging Reporting and Data System Category 5 (LI-RADS LR-5): MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.

Chen J, Zhou J, Kuang S, Zhang Y, Xie S, He B, Deng Y, Yang H, Shan Q, Wu J, Sirlin CB, Wang J.

AJR Am J Roentgenol. 2019 May 23:1-10. doi: 10.2214/AJR.19.21168. [Epub ahead of print]

PMID:
31120791
2.

Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes.

Mangla N, Ajmera VH, Caussy C, Sirlin C, Brouha S, Bajwa-Dulai S, Madamba E, Bettencourt R, Richards L, Loomba R.

Clin Gastroenterol Hepatol. 2019 May 14. pii: S1542-3565(19)30513-0. doi: 10.1016/j.cgh.2019.05.003. [Epub ahead of print] No abstract available.

PMID:
31100460
3.

Role of US LI-RADS in the LI-RADS Algorithm.

Rodgers SK, Fetzer DT, Gabriel H, Seow JH, Choi HH, Maturen KE, Wasnik AP, Morgan TA, Dahiya N, O'Boyle MK, Kono Y, Sirlin CB, Kamaya A.

Radiographics. 2019 May-Jun;39(3):690-708. doi: 10.1148/rg.2019180158.

PMID:
31059393
4.

Novel MRI assessment of treatment response in HIV-associated NAFLD: a randomized trial of an SCD1 inhibitor (ARRIVE Trial).

Ajmera VH, Cachay E, Ramers C, Vodkin I, Bassirian S, Singh S, Mangla N, Bettencourt R, Aldous JL, Park D, Lee D, Blanchard J, Mamidipalli A, Boehringer A, Aslam S, Leinhard OD, Richards L, Sirlin C, Loomba R.

Hepatology. 2019 Apr 23. doi: 10.1002/hep.30674. [Epub ahead of print]

PMID:
31013363
5.

Inter- and intra-reader agreement for gadoxetic acid-enhanced MRI parameter readings in patients with chronic liver diseases.

Beer L, Mandorfer M, Bastati N, Poetter-Lang S, Tamandl D, Stoyanova DP, Elmer MC, Semmler G, Simbrunner B, Hodge JC, Sirlin CB, Reiberger T, Ba-Ssalamah A.

Eur Radiol. 2019 Apr 18. doi: 10.1007/s00330-019-06182-z. [Epub ahead of print]

PMID:
31001679
6.

Is It Time to Expand the Definition of Washout Appearance in LI-RADS?

Fowler KJ, Sirlin CB.

Radiology. 2019 Jun;291(3):658-659. doi: 10.1148/radiol.2019190552. Epub 2019 Apr 16. No abstract available.

PMID:
30990765
7.

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease.

Caussy C, Tripathi A, Humphrey G, Bassirian S, Singh S, Faulkner C, Bettencourt R, Rizo E, Richards L, Xu ZZ, Downes MR, Evans RM, Brenner DA, Sirlin CB, Knight R, Loomba R.

Nat Commun. 2019 Mar 29;10(1):1406. doi: 10.1038/s41467-019-09455-9.

8.

An update for LI-RADS: Version 2018. Why so soon after version 2017?

Kielar AZ, Chernyak V, Bashir MR, Do RK, Fowler KJ, Santillan C, Sirlin CB, Mitchell DG, Cerny M, Tang A, Elsayes KM, Kamaya A, Kono Y, Arora SS.

J Magn Reson Imaging. 2019 Mar 12. doi: 10.1002/jmri.26715. [Epub ahead of print] No abstract available.

PMID:
30864185
9.

Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography.

Zhang YN, Fowler KJ, Ozturk A, Potu CK, Louie AL, Montes V, Henderson WC, Wang K, Andre MP, Samir AE, Sirlin CB.

J Magn Reson Imaging. 2019 Mar 12. doi: 10.1002/jmri.26716. [Epub ahead of print] Review.

PMID:
30859677
10.

Collagen Formation Assessed by N-Terminal Propeptide of Type 3 Procollagen Is a Heritable Trait and Is Associated With Liver Fibrosis Assessed by Magnetic Resonance Elastography.

Caussy C, Bhargava M, Villesen IF, Gudmann NS, Leeming DJ, Karsdal MA, Faulkner C, Bao D, Liu A, Lo MT, Bettencourt R, Bassirian S, Richards L, Brenner DA, Chen CH, Sirlin CB, Loomba R.

Hepatology. 2019 Mar 12. doi: 10.1002/hep.30610. [Epub ahead of print]

PMID:
30859582
11.

Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observations.

Hong CW, Park CC, Mamidipalli A, Hooker JC, Fazeli Dehkordy S, Igarashi S, Alhumayed M, Kono Y, Loomba R, Wolfson T, Gamst A, Murphy P, Sirlin CB.

Eur Radiol. 2019 Feb 26. doi: 10.1007/s00330-019-06058-2. [Epub ahead of print]

PMID:
30809719
12.

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.

Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB.

J Hepatocell Carcinoma. 2019 Feb 5;6:49-69. doi: 10.2147/JHC.S186239. eCollection 2019. Review.

13.

Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD.

Han A, Zhang YN, Boehringer AS, Andre MP, Erdman JW Jr, Loomba R, Sirlin CB, O'Brien WD Jr.

Eur Radiol. 2019 Feb 19. doi: 10.1007/s00330-019-06035-9. [Epub ahead of print]

PMID:
30783789
14.

Pilot study on longitudinal change in pancreatic proton density fat fraction during a weight-loss surgery program in adults with obesity.

Covarrubias Y, Fowler KJ, Mamidipalli A, Hamilton G, Wolfson T, Leinhard OD, Jacobsen G, Horgan S, Schwimmer JB, Reeder SB, Sirlin CB.

J Magn Reson Imaging. 2019 Jan 30. doi: 10.1002/jmri.26671. [Epub ahead of print]

PMID:
30701611
15.

CT/MR LI-RADS 2018: clinical implications and management recommendations.

Kamath A, Roudenko A, Hecht E, Sirlin C, Chernyak V, Fowler K, Mitchell DG.

Abdom Radiol (NY). 2019 Apr;44(4):1306-1322. doi: 10.1007/s00261-018-1868-6. Review.

PMID:
30671612
16.

Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.

Schwimmer JB, Ugalde-Nicalo P, Welsh JA, Angeles JE, Cordero M, Harlow KE, Alazraki A, Durelle J, Knight-Scott J, Newton KP, Cleeton R, Knott C, Konomi J, Middleton MS, Travers C, Sirlin CB, Hernandez A, Sekkarie A, McCracken C, Vos MB.

JAMA. 2019 Jan 22;321(3):256-265. doi: 10.1001/jama.2018.20579.

PMID:
30667502
17.

Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI-RADS).

Chernyak V, Fowler KJ, Heiken JP, Sirlin CB.

J Magn Reson Imaging. 2019 May;49(5):1236-1252. doi: 10.1002/jmri.26540. Epub 2019 Jan 4. Review.

PMID:
30609194
18.

Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease.

Caussy C, Ajmera VH, Puri P, Hsu CL, Bassirian S, Mgdsyan M, Singh S, Faulkner C, Valasek MA, Rizo E, Richards L, Brenner DA, Sirlin CB, Sanyal AJ, Loomba R.

Gut. 2018 Dec 19. pii: gutjnl-2018-317584. doi: 10.1136/gutjnl-2018-317584. [Epub ahead of print]

PMID:
30567742
19.

Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study.

Pooler BD, Wiens CN, McMillan A, Artz NS, Schlein A, Covarrubias Y, Hooker J, Schwimmer JB, Funk LM, Campos GM, Greenberg JA, Jacobsen G, Horgan S, Wolfson T, Gamst AC, Sirlin CB, Reeder SB.

Radiology. 2019 Mar;290(3):682-690. doi: 10.1148/radiol.2018181134. Epub 2018 Dec 18.

PMID:
30561273
20.

Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity.

Yu EL, Golshan S, Harlow KE, Angeles JE, Durelle J, Goyal NP, Newton KP, Sawh MC, Hooker J, Sy EZ, Middleton MS, Sirlin CB, Schwimmer JB.

J Pediatr. 2019 Apr;207:64-70. doi: 10.1016/j.jpeds.2018.11.021. Epub 2018 Dec 14.

PMID:
30559024

Supplemental Content

Loading ...
Support Center